IMS LifeLink PharMetrics Plus⢠â U.S. - IMS Health
IMS LifeLink PharMetrics Plus⢠â U.S. - IMS Health
IMS LifeLink PharMetrics Plus⢠â U.S. - IMS Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
GLOBAL PATIENT-CENTERED ANALYTICS AND SERVICES<br />
<strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus – U.S.<br />
Real World Evidence. Real World Impact.<br />
<strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus brings you<br />
details on the real-world treatment experience<br />
and health outcomes of more than 150 million<br />
unique patients.<br />
<strong>IMS</strong> <strong>Health</strong> introduces <strong>LifeLink</strong><br />
<strong>PharMetrics</strong> Plus, the largest,<br />
most comprehensive database<br />
of integrated medical claims in<br />
the United States. The depth<br />
and breadth of the coverage<br />
provides new patient- and<br />
physician-level insights.<br />
Key Information Types<br />
• Diagnoses and Procedures<br />
• Retail and Mail Order Prescriptions<br />
• Inpatient details—Admitting Diagnosis,<br />
Admission Source & Type<br />
• Provider/Pharmacy ID<br />
• Pharmacy Benefit Design—Co-pay/<br />
Coinsurance Amount; Deductible Amount<br />
• Costs of Services and Prescriptions<br />
• Place of Service<br />
• Plan Type and Time Enrolled<br />
RWEinfo@imshealth.com<br />
+1 (703) 837 5150<br />
www.imshealth.com/rwe<br />
NEW INSIGHTS<br />
As global market dynamics have placed increasing importance<br />
on evidence that proves the value of health technologies, the<br />
demand for HEOR guidance has grown. Yet, historical challenges<br />
stemming from the quality of data, gaps between data sets,<br />
and the need for specialized technical skills have remained.<br />
To power your research more effectively, <strong>IMS</strong> brings you <strong>IMS</strong><br />
<strong>LifeLink</strong> <strong>PharMetrics</strong> Plus with health plan claims information<br />
on 150 million de-identified lives in the U.S.—all in a single,<br />
database. Rich details down to the three-digit ZIP Code level<br />
and from 2006 onward include:<br />
• Diagnosis, procedures and prescriptions spanning all<br />
therapy areas<br />
• Provider identities for billing, rendering and attending<br />
physicians across all healthcare settings<br />
• Insurance provisions such as co-pays and deductibles<br />
The depth and breadth of this coverage allows you to study<br />
sub-populations of patients, while streamlining your costs for<br />
claims data. Because we de-identify the data at the patient<br />
level using <strong>IMS</strong>’ patented technology, you can integrate<br />
<strong>PharMetrics</strong> Plus with other <strong>IMS</strong> databases or with your own<br />
patient-level data sets for research.<br />
A TRUSTED SOURCE<br />
Through an agreement with <strong>Health</strong> Intelligence Company LLC,<br />
<strong>IMS</strong> has exclusive rights to the organization's healthcare claims<br />
database for use in the biopharmaceutical market. The data<br />
are amassed from the member plans within HIC, the operating<br />
arm of Blue <strong>Health</strong> Intelligence, and comingled with <strong>IMS</strong> data<br />
from various sources throughout the U.S., including commercial<br />
health and managed care plans.<br />
Our four-step certification and quality-control process<br />
ensures that the data meet our exacting standards and are<br />
HIPAA compliant.<br />
<strong>IMS</strong> HEALTH | 1725 DUKE STREET, SUITE 510, ALEXANDRIA, VA 22314, USA
GLOBAL PATIENT-CENTERED ANALYTICS AND SERVICES<br />
<strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus – U.S.<br />
ENABLING RIGOROUS ANALYTICS<br />
With the granularity that such a comprehensive dataset provides, <strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong><br />
Plus serves as the foundation for:<br />
• HEOR studies that measure the comprehensive Burden of Illness across settings of care,<br />
Total Cost of Care, Patient Treatment Patterns, Adherence and Persistence to Treatment,<br />
Disease Incidence, Prevalence and Safety<br />
• Market Access initiatives such as Value Preparation and HTA readiness<br />
• Commercial activities that rely on an understanding of the patient experience, including<br />
Adherence & Compliance programs, Segmentation exercises (provider and patient) and<br />
Patient Flow mapping<br />
COMPATIBILITY ACROSS PATIENT-LEVEL DATA SOURCES<br />
Because we de-identify the data at the patient level, <strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus:<br />
• Is compatible with a range of supplemental, proprietary <strong>LifeLink</strong> data assets including<br />
EMR,Longitudinal Prescription, and Demographic sets encompassing more than 240 million<br />
U.S. patients<br />
• Through <strong>IMS</strong> customized solutions, can be integrated with other traditionally disparate<br />
data sets including internal data (e.g., RCT), <strong>IMS</strong> data, and additional third-party data<br />
• Through de-identification technology, <strong>PharMetrics</strong> Plus and other <strong>IMS</strong> assets are<br />
scalable over time as new data sources are acquired to close gaps at the therapeutic<br />
level and beyond<br />
COMPREHENSIVE SUPPORT<br />
Our focus extends beyond data solutions by providing comprehensive tools and support services<br />
and investing in technologies that support your current and future global needs. We offer:<br />
• Technology solutions to provide efficient interrogation of the data, including structured<br />
analytic, visualization and reporting features.<br />
• A team of more than 200 HEOR staff members across 18 countries who are available to<br />
help you analyze, interpret and communicate your research results.<br />
• Global partnerships including a collaboration with the UK’s National <strong>Health</strong> Service<br />
observational data and interventional research service, Clinical Practice Research Datalink.<br />
2011 SAMPLE COUNTS FOR PATIENTS WITH MEDICAL AND PHARMACY COVERAGE<br />
>4.5 million<br />
patients<br />
>1.3 million<br />
patients<br />
250 thousand<br />
patients<br />
Hypertension Asthma Breast Cancer<br />
With the richness of insights available in <strong>IMS</strong> <strong>LifeLink</strong> <strong>PharMetrics</strong> Plus, <strong>IMS</strong> is leading<br />
the way to a greater understanding of the value of medical technologies—and more<br />
productive dialogues with a range of healthcare stakeholders.<br />
To find out more about the way that <strong>IMS</strong> can help you benefit from comprehensive<br />
patient-level information, please email RWEinfo@imshealth.com<br />
<strong>IMS</strong> HEALTH | 1725 DUKE STREET, SUITE 510, ALEXANDRIA, VA 22314, USA<br />
© 2012 <strong>IMS</strong> <strong>Health</strong> Incorporated and its affiliates. All rights reserved.<br />
Trademarks are registered in the United States and in various other countries.<br />
HEORPM1012